Cerus (CERS) FCF Margin Growth (1y) (2011 - 2026)
Cerus (CERS) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -1,716.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 2,833.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -125.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2,811.00 |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | -391.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -391.00 |
| Dec 31, 2025 | -182.00 |
| Sep 30, 2025 | -47,993.00 |
| Jun 30, 2025 | -53,557.00 |
| Mar 31, 2025 | -445.00 |
| Dec 31, 2024 | 1,368.00 |
| Sep 30, 2024 | 798,061.00 |
| Jun 30, 2024 | 2,549.00 |
| Mar 31, 2024 | 7,370.00 |
| Dec 31, 2023 | -658.00 |
| Sep 30, 2023 | -746,056.00 |
| Jun 30, 2023 | -2,326.00 |
| Mar 31, 2023 | 7,426.00 |
| Dec 31, 2022 | -13.00 |
| Sep 30, 2022 | 7,509.00 |
| Jun 30, 2022 | 5,833.00 |
| Mar 31, 2022 | 3,690.00 |
| Dec 31, 2021 | 856.00 |
| Sep 30, 2021 | 76,914.00 |
| Jun 30, 2021 | -146.00 |